High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: Filgrastim (G-CSF)|DRUG: Cyclophosphamide|DRUG: Doxorubicin Hydrochloride|DRUG: Paclitaxel|PROCEDURE: Peripheral Blood Stem Cell Transplantation
Sponsor: M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)|Bristol-Myers Squibb